Health Care - Life Science & Diagnostic Tools: 2011 Second
Institutional Investor Research is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Health Care - Life Science & Diagnostic Tools: 2011 Second

Deutsche Bank Securities’ Ross Muken, who works out of San Francisco and “is always on the cutting edge,” according to one buy-side backer, advances one level to the second tier. In January, Muken advised investors to buy Thermo Fisher Scientific

Register (free), subscribe or login to access this page:

Unlock essential data and insights

      • Register (free) for top line Survey Results and most Editorial content
      • Subscribe for full access to our unique data and premium editorial
Gift this article